Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences

$OCULPress releaseOct 29, 2026, 7:00 AM ETRead the release

Ocular Therapeutix announced participation in several November 2026 investor and scientific conferences, including a UBS Global Biopharma Conference fireside chat on November 17. CEO Pravin Dugel will present the fireside chat, and CSO Jeffrey Heier will present at The Empire Forum and an nAMD symposium in New York.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.